Universal Ibogaine Inc. (TSXV:IBO)
Canada flag Canada · Delayed Price · Currency is CAD
0.0050
-0.0050 (-50.00%)
At close: Feb 2, 2026

Universal Ibogaine Cash Flow Statement

Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20
Net Income
-1.48-2.05-2.39-10.5-3.87-5.57
Depreciation & Amortization
0.350.340.30.270.071
Loss (Gain) From Sale of Assets
0.980.980.36---
Asset Writedown & Restructuring Costs
-0.36--2.71-2.15
Stock-Based Compensation
0.070.090.120.9--
Other Operating Activities
0.020.020.022.790.830.45
Change in Accounts Receivable
-0.39-0.120.16---0.02
Change in Accounts Payable
-0.08-0.130.23-0.470.280.11
Change in Unearned Revenue
0.260.030.11---
Change in Other Net Operating Assets
-0.01-0.010.01-0.03-0.56-0.46
Operating Cash Flow
-0.64-0.84-1.1-4.33-3.25-2.33
Capital Expenditures
-0.02-0.08-0.36-0.1--
Sale of Property, Plant & Equipment
---0.01--
Cash Acquisitions
----2.05-0.04-
Other Investing Activities
---0.04--
Investing Cash Flow
-0.02-0.08-0.36-2.09-0.04-
Short-Term Debt Issued
--0.31.630.330.08
Long-Term Debt Issued
--0.81-0.06-
Total Debt Issued
--1.111.630.390.08
Short-Term Debt Repaid
---0.06-0.42-0.1-0.07
Long-Term Debt Repaid
--0.23-0.01---
Total Debt Repaid
-0.22-0.23-0.07-0.42-0.1-0.07
Net Debt Issued (Repaid)
-0.22-0.231.031.210.290
Issuance of Common Stock
0.221.210.016.093.342.39
Other Financing Activities
0.32-0.01--0.29-0.25-0.02
Financing Cash Flow
0.320.971.047.013.382.37
Net Cash Flow
-0.340.06-0.410.580.090.04
Free Cash Flow
-0.66-0.92-1.46-4.43-3.25-2.33
Free Cash Flow Margin
-32.20%-39.35%-141.50%-413.60%--
Free Cash Flow Per Share
-0.00-0.00-0.01-0.02-0.03-0.07
Cash Interest Paid
0.170.160.10.070.02-
Levered Free Cash Flow
-0.37-0.95-0.81-1.47-2.57-0.99
Unlevered Free Cash Flow
-0.27-0.85-0.72-1.42-2.56-0.99
Change in Working Capital
-0.23-0.230.5-0.51-0.28-0.37
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.